₹539.65
-4.95 (-0.91%)
As of 17 Sept 2026, Thyrocare Technologies Ltd share price is ₹539.65. The stock opened at ₹539.65 and had closed at ₹544.60 the previous day. Over the last 52 weeks, the stock has recorded a low of ₹342.55 and a high of ₹662.00. In terms of performance, Thyrocare Technologies Ltd share price has increased by 44.74% over the past six months and has increased by 35.45% over the last year.
THYROCARE Stock Price Chart
Thyrocare Technologies Ltd Overview
Market cap₹8,589 Crs
Volume16,154
Prev. Close₹544.60
Year range₹342.55 - ₹662.00
ISININE594H01019
About THYROCARE
Thyrocare Technologies operates in the healthcare industry and is involved in providing quality diagnostic services to patients.
Thyrocare Technologies Ltd Historical Performance
1 Month Return-12.71%
6 Month Return49.74%
3 Year Return184.39%
3 Month Return1.23%
1 Year Return35.72%
5 Year Return27.56%
Thyrocare Technologies Ltd Fundamentals
ROCE(TTM)34.25%
P/E Ratio (TTM)52.70
P/B Ratio17.52
Debt to Equity0.09
ROE26.54%
EPS (TTM)10.50
Dividend Yield2.59%
Book Value30.80
Profit Margin20.36%
Operating Margin27.04%
Thyrocare Technologies Ltd Financials
| Indicator | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Revenue | 787.66 | 646.44 | 531.20 | 491.85 | 568.93 |
| EBITDA | 263.75 | 200.36 | 141.06 | 117.40 | 238.23 |
| Net Profit | 148.81 | 95.78 | 71.14 | 56.97 | 152.05 |
| EPS | 9.36 | 17.95 | 13.44 | 10.77 | 28.75 |
Thyrocare Technologies Ltd Technical Analysis
| Indicator | Value |
|---|---|
| Support 1 (S1) | 540.05 |
| Resistance 1 (R1) | 552.65 |
| Pivot Point | 548.10 |
Thyrocare Technologies Ltd Dividend History
| Ex Date | Dividends Date | Record Date | Dividend Type | Dividend Details |
|---|---|---|---|---|
| 23-Jun-2026 | 07-May-2026 | 23-Jun-2026 | Final | ₹7.00 |
| 24-Oct-2025 | 14-Oct-2025 | 24-Oct-2025 | Interim | ₹7.00 |
| 25-Jul-2025 | 23-Apr-2025 | 25-Jul-2025 | Final | ₹21.00 |
| 16-Aug-2024 | 14-May-2024 | 16-Aug-2024 | Final | ₹18.00 |
| 20-Apr-2023 | 07-Apr-2023 | 20-Apr-2023 | Interim | ₹18.00 |
THYROCARE Key Leadership Details
Last Updated: Mar 2026
| Name | Position |
|---|---|
| Rahul Franklin Guha | Chairman & Managing Director |
| Alok Kumar Jagnani | Non Executive Independent Director |
| Uday Patel Kadam | Non Executive Independent Director |
Thyrocare Technologies Ltd Peer Comparison
| Company | Price | M.Cap (Cr) | P/E (TTM) | ROE (TTM) |
|---|---|---|---|---|
| Apollo Hospitals Enterprise LtdAPOLLOHOSP | ₹8,696.50-0.20% | ₹1,10,231.07 | 59.08 | 20.48% |
| Max Healthcare Institute LtdMAXHEALTH | ₹1,025.00-0.49% | ₹1,02,534.79 | 72.27 | 13.42% |
| Fortis Healthcare LtdFORTIS | ₹870.30-1.11% | ₹68,746.49 | 70.10 | 10.53% |
Disclaimer
The information provided on this page is for informational purposes only and should not be construed as investment advice, recommendation, or solicitation to buy or sell any securities or financial pr...
Frequently Asked Questions
- The share price of Thyrocare Technologies Ltd today is ₹539.65 on NSE and ₹539.65 on BSE.
- The 52-week high of Thyrocare Technologies Ltd is ₹662.00, while the 52-week low is ₹342.55.
- The current market capitalisation of Thyrocare Technologies Ltd is approximately ₹8,589 crore.
- The P/E (Price-to-Earnings) ratio of Thyrocare Technologies Ltd is 44.12. The ratio may vary with changes in the share price and earnings.
- The P/B (Price-to-Book) ratio of Thyrocare Technologies Ltd is 11.21. It compares the company’s market value with its book value and can provide an indication of how the market values the company relative to its net assets.
- To buy Thyrocare Technologies Ltd shares, you first need to open a demat account before you can place an order. Here's the process:
• Open a demat account online using your PAN, Aadhaar and bank details.
• Add funds to your trading account via UPI or net banking.
• Search for THYROCARE on TradeMobi or the Anand Rathi web platform.
• Place your order
• Track your holdings in the portfolio section. - Over the past 3 years, Thyrocare Technologies Ltd has delivered a return of approximately 184.39%. This return is based on the change in the share price over the specified period and may differ depending on the measurement date. Past performance does not guarantee future returns.
- The shareholding pattern of Thyrocare Technologies Ltd comprises different categories of shareholders. As of Jun 2026, the shareholding is approximately 60.92% promoters, -14.42% FIIs, 20.92% DIIs, and 10.35% public shareholders.
Download TradeMobi App
- Real-Time Market Data
- Advanced Trading Tools
- Expert-Backed Research
